These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7903212)

  • 1. European experience with artex: the Tertatolol International Multicentre Study (TIMS).
    Laher MS
    Cardiology; 1993; 83 Suppl 1():25-31. PubMed ID: 7903212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Tertatolol International Multicenter Study (T.I.M.S.). Predicting factors of an efficient therapy.
    Agnes E; Vandermercken C; Prost JF; Safar ME
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):296S-302S. PubMed ID: 2573379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tertatolol in hypertension. Long-term therapy in 2,338 patients.
    Guery O; Herpin D; Lecasble M; Piron J
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):289S-295S. PubMed ID: 2573378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of clinical safety and efficacy of tertatolol.
    Vivet P
    Cardiology; 1993; 83 Suppl 1():41-50. PubMed ID: 7903214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of tertatolol on lipid profile.
    Diehm C; Jacobsen O; Amendt K
    Cardiology; 1993; 83 Suppl 1():32-40. PubMed ID: 7903213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term experience with tertatolol in hypertension.
    Komajda M; Genevray B; Grosgogeat Y
    Am J Nephrol; 1986; 6 Suppl 2():106-12. PubMed ID: 2879465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive effects of tertatolol. A comparative study versus atenolol.
    Mota JC; Carrageta MD; Felix S; Nunes AM; Jobbé-Duval M
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):284S-288S. PubMed ID: 2573377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular response to adrenergic stimulation during treatment with tertatolol. A new non-cardioselective beta-blocking agent in primary hypertensive patients.
    Fasano ML; Gaeta I; De Simone G; Iannuzzi R; Ferrara LA
    Jpn Heart J; 1991 Jul; 32(4):435-44. PubMed ID: 1683411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional benefits of combining beta-blockade and renal vasodilation in the treatment of mild to moderate hypertension: Tertatolol International Multicentre Study results.
    Agnes E; Prost JF; Laher MS
    J Hypertens Suppl; 1989 Dec; 7(6):S270-1. PubMed ID: 2576668
    [No Abstract]   [Full Text] [Related]  

  • 10. Antihypertensive effects of tertatolol: 3-month comparative study against acebutolol.
    Gallet M; Kleinknecht D; Maurice P
    Am J Nephrol; 1986; 6 Suppl 2():83-7. PubMed ID: 2879477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and tolerability of tertatolol in the treatment of mild to moderate arterial hypertension. Results of a French multicenter study with 2,338 patients treated over one year].
    Herpin D; Piron J; Bajou B; Lecasble M
    Ann Cardiol Angeiol (Paris); 1989 Oct; 38(8):503-7. PubMed ID: 2574560
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of long-term antihypertensive treatment with tertatolol on diastolic function in hypertensive patients with and without left ventricular hypertrophy.
    Trimarco B; DeLuca N; Rosiello G; Ricciardelli B; Marchegiano R; Condorelli G; Raponi M; Condorelli M
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):278S-283S. PubMed ID: 2573376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative renal and cardiac effects of tertatolol and enalapril in essential hypertension.
    Ribstein J; Du Cailar G; Brouard R; Mimran A
    Cardiology; 1993; 83 Suppl 1():57-63. PubMed ID: 7903217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of novel renal properties of tertatolol.
    Guillet C
    Cardiology; 1993; 83 Suppl 1():64-9. PubMed ID: 7903218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal and systemic effects of atenolol and tertatolol in renal transplant recipients on cyclosporine A.
    Branten AJ; Hilbrands LB; van Hamersvelt HW; Koene RA; Huysmans FT
    Nephrol Dial Transplant; 1998 Feb; 13(2):423-6. PubMed ID: 9509456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tertatolol in hypertensive patients with chronic renal failure.
    Beaufils M; Lantz B; Paillard F; Richet G
    Am J Nephrol; 1986; 6 Suppl 2():50-4. PubMed ID: 2879474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal effects of intravenous tertatolol in essential arterial hypertension].
    Chaignon M; Brouard R; Lucsko M; Guédon J
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1219-22. PubMed ID: 1979729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patients.
    Salvetti A; Leonetti G; Bernini GP; Rupoli L; Lucarini AR; Sangiorgio P; Mauro M; Di Stratis P; Zanchetti A
    Am J Nephrol; 1986; 6 Suppl 2():45-9. PubMed ID: 2879473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-Blockers in the Treatment of Hypertension in the 90's: Experience with Tertatolol. Conference proceedings. Istanbul, Turkey, October 19, 1993.
    Cardiology; 1993; 83 Suppl 1():1-72. PubMed ID: 7903209
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study of the effectiveness and acceptability of tertatolol 5 mg and acebutolol 400mg in the treatment of mild arterial hypertension].
    Gallet M; Lestaevel M; Lopez M; Manchon J; Brodsky D
    Ann Med Interne (Paris); 1987; 138 Suppl 1():31-4. PubMed ID: 2884914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.